UniSa - IRIS Institutional Research Information System

RAIMONDO, ANNUNZIATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.094
EU - Europa 3.461
AS - Asia 3.197
SA - Sud America 354
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 50
OC - Oceania 4
AN - Antartide 1
Totale 12.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.001
IT - Italia 1.597
HK - Hong Kong 1.495
FI - Finlandia 1.199
SG - Singapore 815
CN - Cina 354
BR - Brasile 253
VN - Vietnam 192
RU - Federazione Russa 150
FR - Francia 93
DE - Germania 89
IN - India 73
IE - Irlanda 64
KR - Corea 62
NL - Olanda 52
SE - Svezia 48
AR - Argentina 47
CA - Canada 42
GB - Regno Unito 42
BD - Bangladesh 39
JP - Giappone 37
MX - Messico 24
PL - Polonia 20
AT - Austria 18
ES - Italia 18
UA - Ucraina 17
EC - Ecuador 16
TR - Turchia 16
CO - Colombia 15
PK - Pakistan 15
IQ - Iraq 14
CH - Svizzera 13
ID - Indonesia 13
ZA - Sudafrica 10
EG - Egitto 9
HR - Croazia 9
PH - Filippine 9
JM - Giamaica 7
TN - Tunisia 7
UZ - Uzbekistan 7
VE - Venezuela 7
JO - Giordania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
LT - Lituania 5
MY - Malesia 5
OM - Oman 5
SA - Arabia Saudita 5
AU - Australia 4
CZ - Repubblica Ceca 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
BE - Belgio 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
IR - Iran 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MU - Mauritius 1
NE - Niger 1
Totale 12.153
Salva come PNG Salva come JPEG
Città #
Dallas 2.847
Hong Kong 1.491
Helsinki 1.182
San Jose 451
Singapore 399
Milan 326
Chandler 231
Rome 192
Ashburn 160
Princeton 149
Beijing 108
Council Bluffs 96
Naples 73
The Dalles 73
Ho Chi Minh City 70
Lauterbourg 70
Moscow 63
Dublin 62
Ann Arbor 52
New York 51
Santa Clara 50
Los Angeles 49
Munich 43
Salerno 36
Tokyo 34
Wilmington 34
Hanoi 31
São Paulo 30
Bari 29
Turin 27
Amsterdam 26
Figino 25
Genoa 24
Houston 23
Seattle 23
Stockholm 21
Bologna 18
Palermo 18
Andover 17
Chennai 17
Orem 17
Warsaw 17
Columbus 16
London 16
Montreal 16
Nuremberg 16
Brooklyn 15
Florence 15
Jacksonville 15
Seoul 15
Denver 14
Dong Ket 14
Fisciano 14
Boston 13
Phoenix 13
Verona 13
Mumbai 12
Turku 12
Woodbridge 12
Catania 11
Frankfurt am Main 11
Boardman 10
Cava de' Tirreni 10
Da Nang 9
Mexico City 9
Pune 9
Albignasego 8
Atlanta 8
Las Vegas 8
Padova 8
Rio de Janeiro 8
San Francisco 8
West Jordan 8
Belo Horizonte 7
Cagliari 7
Charlotte 7
Chicago 7
Cinisello Balsamo 7
Guangzhou 7
Sarno 7
Taranto 7
Thái Nguyên 7
Venice 7
Asti 6
Baghdad 6
Buenos Aires 6
Haiphong 6
Jakarta 6
Lahore 6
Lamezia Terme 6
Messina 6
Napoli 6
Poplar 6
Quito 6
Rimini 6
Toronto 6
Acerra 5
Addis Ababa 5
Barcelona 5
Brasília 5
Totale 9.289
Salva come PNG Salva come JPEG
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 3.990
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 893
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 482
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 441
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 250
Psoriasi eritrodermica: rapida efficacia di bimekizumab 214
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 170
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 153
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 140
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 133
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection 133
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 132
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 124
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 123
Atopic dermatitis: Epidemiology and clinical phenotypes 112
Presence of BAG3 protein in serum samples from patients affected by psoriasis 110
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 110
Photosensitivity and cancer immune-targeted therapies 109
Interleukin-33: increasing role in dermatological conditions 109
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 104
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 101
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 101
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 94
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review 89
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 88
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 88
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 86
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 86
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 86
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 85
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 85
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 85
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 81
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 81
The laboratory role in the assessment of sensitization and irritation potential of cosmetics 81
IL-33 is regulated by TNF-α in normal and psoriatic skin 80
A journey into psoriasis: From the adipose tissue to the skin 79
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions 78
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 76
RAST: Clinical applications 76
Guselkumab for the treatment of psoriasis 75
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 74
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 74
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 73
IL-26 in allergic contact dermatitis: Resource in a state of readiness 73
Clinical predictors of psoriatic arthritis and osteoclast differentiation 73
A potential prognostic test for bone erosion development in patients with cutaneous predictive sites for psoriatic arthritis 73
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 72
The role of the dermatologist in the immune-mediated/allergic diseases – position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum 70
Polymorphic light eruption: What's new in pathogenesis and management 66
Psoriasis, cardiovascular events, and biologics: Lights and shadows 66
Flash-pumped pulsed dye laser for vascular skin lesions: our experience and an overview of the literature 66
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 66
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 64
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 64
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 64
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 64
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 62
IL-26: A new actor in allergic contact dermatitis 59
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 58
The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa 58
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 57
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 55
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 54
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 52
Guselkumab e psoriasi in sedi difficili: efficacia ed impatto sulla qualità di vita in pazienti naive o bio experienced 51
Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study 51
Ultrasonography in the management of a recurrent and eruptive lobular capillary hemangioma and resolution with intense pulsed light 51
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross-sectional study in Italy 51
New insights into mechanism of Notch signaling in hidradenitis suppurativa 50
UVB-induced p53 is reduced by a mixture of natural extracts 50
Systemic inflammation: psoriasis as a model…in Naples 49
Photodermatoses and Skin Cancer 49
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 47
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 46
Psoriasi e terapia con guselkumab: panoramica 2022 dal centro prescrittore AOU Salerno 46
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy 44
Studio osservazionale descrittivo per la valutazione della prevalenza della psoriasi nei pazienti adulti dislipidemici in terapia monoclonale con anti-PCSK9 43
Novel interactions among ultraviolet B, skin and adipose tissue 42
Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future 40
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study 38
Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series 37
Letters to the editor 37
Dermatite atopica e stress ossidativo: nuovi biomarker 34
The role of the RNA-binding protein AUF-1 in chronic inflammatory skin diseases and cellular senescence 31
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study 11
Totale 12.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022253 0 4 3 20 30 2 0 11 21 5 40 117
2022/2023544 55 56 27 74 27 102 6 53 87 15 27 15
2023/2024541 23 54 39 26 35 45 28 46 18 66 54 107
2024/20251.533 65 36 115 137 79 187 169 86 240 88 145 186
2025/20268.930 252 1.644 2.755 316 478 243 648 144 1.389 463 162 436
2026/2027271 207 64 0 0 0 0 0 0 0 0 0 0
Totale 12.268